‍Weight Loss That Won’t Weigh on Your Wallet‍

Switch seamlessly. Keep the same dose, with better support from HeMed.

Wegovy or Mounjaro shipped discreetly to you

24/7 side effect support

Start safely with an included blood test

Your health and safety come first. We begin with a simple no-needle at home blood test to screen key health markers. This not only ensures treatment is safe and tailored to you, but also helps you understand how our programme supports your overall health not just your weight.

An image of the SheMed GLP-1 Screening Kit and an iPhone displaying the SheMed Weight Loss Program app.

We are here to help you in every step

Your dose schedule will be set by our clinical team, who will carefully consider your weight loss progress,
side effects, medical history, and personal preferences to determine the best path for you.

Dose

Price

0.25 mg

£139 £75*

0.5 mg

£139 £75*

1 mg

£139

1.7 mg

£159

2.4 mg

£159

About Wegovy

Wegovy is a weight loss medication that contains the active ingredient semaglutide. It mimics the GLP-1 hormone to help regulate appetite and reduce hunger.

20.5% average weight loss*

Approved for MACE (major adverse cardiovascular events)

Available in 5 strengths to support tailored treatment plans

*Novo Nordisk: Higher dose of Wegovy provided average weight loss of 21% in people with obesity, with a third achieving 25% or more, according to data presented at ADA.

You are in control of your journey

Your dose schedule will be determined by our clinical team to ensure the right path for you.
However, we will never move you into a higher pricing tier without your permission.

Dose

Price

2.5 mg

£229 £169

5 mg

£229 £179

7.5 mg

£279 £229

10 mg

£279 £229

12.5 mg

£319 £269

15 mg

£319 £269

About Mounjaro

Mounjaro is a weight loss medication that contains the active ingredient tirzepatide. It helps curb appetite, slows digestion, and improves how your body processes food.

22.5% average weight loss*

NOT approved for MACE (major adverse cardiovascular events)

Available in 6 strengths to support tailored treatment plans

*Tirzepatide as compared with semaglutide for the treatment of obesity.
‍New England Journal of Medicine. Advance online publication.